Ignite Creation Date:
2024-05-05 @ 11:47 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00134810
Status:
COMPLETED
Last Update Posted:
2019-11-22
First Post:
2005-08-23
Brief Title:
Study to Assess the Efficacy and Safety of Dysport in Upper Back Myofascial Pain Syndrome
Sponsor:
Ipsen
Organization:
Ipsen
Study Overview
Official Title:
A Phase II Multicentre Multinational Prospective Randomised Double-blind Placebo-controlled Study Assessing the Efficacy and Safety of a Single Application of Three Doses of Dysport in Patients With Upper Back Myofascial Pain Syndrome
Status:
COMPLETED
Status Verified Date:
2019-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main purpose of this study is to determine which is the best dose of a drug known as Dysport to give when treating ones type of upper back pain The study will also examine the side effects of this treatment and its overall effect on ones disorder
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2004-001845-13 | EUDRACT_NUMBER | None | None |